"Insulin Resistance" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS.
| Descriptor ID |
D007333
|
| MeSH Number(s) |
C18.452.394.968.500 G07.690.773.984.617
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Insulin Resistance".
Below are MeSH descriptors whose meaning is more specific than "Insulin Resistance".
This graph shows the total number of publications written about "Insulin Resistance" by people in this website by year, and whether "Insulin Resistance" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 0 | 4 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 0 | 1 |
| 2000 | 1 | 2 | 3 |
| 2001 | 5 | 3 | 8 |
| 2002 | 3 | 5 | 8 |
| 2003 | 3 | 1 | 4 |
| 2004 | 7 | 6 | 13 |
| 2005 | 8 | 5 | 13 |
| 2006 | 10 | 11 | 21 |
| 2007 | 7 | 9 | 16 |
| 2008 | 7 | 7 | 14 |
| 2009 | 8 | 8 | 16 |
| 2010 | 10 | 10 | 20 |
| 2011 | 22 | 11 | 33 |
| 2012 | 20 | 20 | 40 |
| 2013 | 10 | 10 | 20 |
| 2014 | 9 | 15 | 24 |
| 2015 | 12 | 12 | 24 |
| 2016 | 11 | 21 | 32 |
| 2017 | 11 | 16 | 27 |
| 2018 | 9 | 14 | 23 |
| 2019 | 6 | 12 | 18 |
| 2020 | 19 | 12 | 31 |
| 2021 | 13 | 9 | 22 |
| 2022 | 21 | 3 | 24 |
| 2023 | 10 | 0 | 10 |
| 2024 | 6 | 1 | 7 |
| 2025 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin Resistance" by people in Profiles.
-
Association of Insulin Resistance With Radiographic Lung Abnormalities and Incident Lung Disease: The Framingham Offspring Study. Diabetes Care. 2025 Jan 01; 48(1):143-148.
-
The role of the triglyceride-glucose index as a biomarker of cardio-metabolic syndromes. Lipids Health Dis. 2024 Dec 23; 23(1):416.
-
Pathophysiology and Treatment of Prediabetes and Type 2 Diabetes in Youth. Diabetes Care. 2024 Dec 01; 47(12):2038-2049.
-
Atypical Diabetes: What Have We Learned and What Does the Future Hold? Diabetes Care. 2024 May 01; 47(5):770-781.
-
Distinct Amino Acid Profile Characterizes Youth With or at Risk for Type 2 Diabetes. Diabetes. 2024 Apr 01; 73(4):628-636.
-
Impact of Insulin Sensitivity and ?-Cell Function Over Time on Glycemic Outcomes in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE): Differential Treatment Effects of Dual Therapy. Diabetes Care. 2024 Apr 01; 47(4):571-579.
-
Increased Plasma Branched Short-Chain Fatty Acids and Improved Glucose Homeostasis: The Microbiome and Insulin Longitudinal Evaluation Study (MILES). Diabetes. 2024 Mar 01; 73(3):385-390.
-
Rosiglitazone improves insulin resistance but does not improve exercise capacity in individuals with impaired glucose tolerance: A randomized clinical study. J Investig Med. 2024 03; 72(3):294-304.
-
Leptin Decreases Gluconeogenesis and Gluconeogenic Substrate Availability in Patients With Lipodystrophy. J Clin Endocrinol Metab. 2023 Dec 21; 109(1):e209-e215.
-
GSK-3? as a Potential Coordinator of Anabolic and Catabolic Pathways in Hepatitis C Virus Insulin Resistance. Intervirology. 2024; 67(1):6-18.